Cutaneous leukocytoclastic vasculitis induced by continuous erythropoietin receptor activator.

Kwon, Hyeok-Jin; Kim, Jung-Hwan; Yoo, Dong-Wha; Kim, Tae-Hoon; Yoon, Jung-Ho; Kim, Ki-Ho

Kwon, Hyeok-Jin; Kim, Jung-Hwan; Yoo, Dong-Wha; Kim, Tae-Hoon; Yoon, Jung-Ho; Kim, Ki-Ho.

Affiliation

Kwon HJ; Department of Dermatology, College of Medicine, Dong-A University, Busan, Republic of Korea.
Kim JH; Department of Dermatology, College of Medicine, Dong-A University, Busan, Republic of Korea.
Yoo DW; Department of Dermatology, College of Medicine, Dong-A University, Busan, Republic of Korea.
Kim TH; Department of Dermatology, College of Medicine, Dong-A University, Busan, Republic of Korea.
Yoon JH; Department of Dermatology, College of Medicine, Dong-A University, Busan, Republic of Korea.
Kim KH; Department of Dermatology, College of Medicine, Dong-A University, Busan, Republic of Korea.

JAAD Case Rep ; 16: 101-104, 2021 Oct.

Article in En | MEDLINE | ID: mdl-34553012

Key words

CERA, continuous erythropoietin receptor activator; CKD, chronic kidney disease; CLCV, cutaneous leukocytoclastic vasculitis; PEG, polyethylene glycol; continuous erythropoietin receptor activator; cutaneous leukocytoclastic vasculitis; immunogenicity; polyethylene glycol; type III hypersensitivity

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JAAD Case Rep Year: 2021 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JAAD Case Rep Year: 2021 Document type: Article